Let’s start up with the current stock price of Arcturus Therapeutics Holdings Inc. (ARCT), which is $113.14 to be very precise. The Stock rose vividly during the last session to $116.40 after opening rate of $97.78 while the lowest price it went was recorded $97.00 before closing at $99.29.
Recently in News on December 8, 2020, Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock. Arcturus Therapeutics Holdings Inc. (the “Company”, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced the pricing of an underwritten public offering of 1,365,000 shares of its common stock at a public offering price of $110.00 per share. The gross proceeds of the offering to the Company are expected to be approximately $150 million, before deducting the underwriting discounts and commissions and other estimated offering expenses. In addition, the Company granted the underwriters a thirty-day option to purchase up to an additional 204,750 shares of common stock at the public offering price, less underwriting discounts and commissions. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Arcturus Therapeutics Holdings Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $129.71 on 12/07/20, with the lowest value was $8.51 for the same time period, recorded on 03/13/20.
Arcturus Therapeutics Holdings Inc. (ARCT) full year performance was 909.28%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Arcturus Therapeutics Holdings Inc. shares are logging -12.77% during the 52-week period from high price, and 1229.49% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $8.51 and $129.71.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1585952 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Arcturus Therapeutics Holdings Inc. (ARCT) recorded performance in the market was 940.85%, having the revenues showcasing 175.08% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 3.05B, as it employees total of 88 workers.
Arcturus Therapeutics Holdings Inc. (ARCT) in the eye of market guru’s
During the last month, 8 analysts gave the Arcturus Therapeutics Holdings Inc. a BUY rating, 2 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 58.47, with a change in the price was noted +58.34. In a similar fashion, Arcturus Therapeutics Holdings Inc. posted a movement of +106.46% for the period of last 100 days, recording 891,806 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ARCT is recording 0.06 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.06.
Arcturus Therapeutics Holdings Inc. (ARCT): Stocks Technical analysis and Trends
Raw Stochastic average of Arcturus Therapeutics Holdings Inc. in the period of last 50 days is set at 82.89%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 76.43%. In the last 20 days, the company’s Stochastic %K was 66.46% and its Stochastic %D was recorded 65.57%.
If we look into the earlier routines of Arcturus Therapeutics Holdings Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 940.85%. Additionally, trading for the stock in the period of the last six months notably improved by 155.40%, alongside a boost of 909.28% for the period of the last 12 months. The shares increased approximately by 5.21% in the 7-day charts and went down by 90.60% in the period of the last 30 days. Common stock shares were driven by 175.08% during last recorded quarter.